|
|
Striving towards the elimination of HCV infection, Berlin 2018
Berlin, Germany 2-3 February 2018
|
Description:
Globally, morbidity and mortality due to HCV infection continues to rise. However, the availability of simple and tolerable DAA therapies for HCV infection with cure rates >90% is one of the greatest medical advances in decades. This has brought considerable optimism to people working in HCV.
Url:
Booking: https://go.evvnt.com/147888-1
Price
EASL Member Early fee: EUR 300
EASL Member: EUR 450
Non Member Early fee: EUR 450
Non Member : EUR 550
Speakers: Prof. Francesco Negro, Dr. Alessio Aghemo, Prof. Jason Grebely
Time: 8:00 am - 4:30 pm
Category: | Conferences | Science, Health and Medicine |
Back